Skip to main content
Top
Published in: Pituitary 4/2019

01-08-2019 | Pituitary Adenoma

Increased frequency of cataract surgery in patients over age 50 with pituitary macroadenomas and chiasmal compression

Authors: Mina M. Gerges, Mohamed M. Arnaout, Abad Cherif El Asri, Matthew D. Cummock, Ahmed Roshdy, Vijay K. Anand, Marc J. Dinkin, Cristiano Oliveira, Theodore H. Schwartz

Published in: Pituitary | Issue 4/2019

Login to get access

Abstract

Background

Patients with visual loss from macroadenomas compressing their optic apparatus may also have concomitant age-related visual pathology such as cataracts. How these two pathologies interact with each other is not well documented.

Objective

The interaction between these two pathologies in elderly patients is the subject of this study.

Methods

We identified a series of non-functioning macroadenoma patients over age 50 years with tumors compressing the chiasm who underwent transsphenoidal surgery at our institution between 2004 and 2018. Pre- and post-operative visual complaints, tumor size and extent of resection were analyzed. Prevalence of the diagnosis of cataract and prevalence of cataract surgery in each decade were compared with national averages.

Results

We identified 200 patients who met selection criteria. 18% of these patients had a diagnosis of cataract and 12.5% had cataract surgery. Compared with the Eye Diseases Prevalence Research Group (EDPRG) study, the prevalence of cataract surgery was 2.5 times the national average of 5.1%. 32% of these patients had no improvement in their vision after cataract surgery but 76% improved after transsphenoidal surgery.

Conclusions

We reported a high prevalence of cataract surgery in patients over age 50 in patients with pituitary macroadenomas compressing the optic pathway compared with national averages in patients without adenomas. While visual loss from adenoma likely precipitated more cataract surgeries in this group of patients, some who may not have required it, those patients with cataracts who did not have their cataracts extracted were less likely to recover vision after transsphenoidal surgery. Addressing both pathologies is beneficial.
Literature
1.
go back to reference World Health Organization (2015) World report on ageing and health. World Health Organization, Geneva World Health Organization (2015) World report on ageing and health. World Health Organization, Geneva
2.
go back to reference Attebo K, Mitchell P, Smith W (1996) Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology 103(3):357–364CrossRefPubMed Attebo K, Mitchell P, Smith W (1996) Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology 103(3):357–364CrossRefPubMed
3.
go back to reference Mitchell P, Cumming RG, Attebo K, Panchapakesan J (1997) Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 104(4):581–588CrossRefPubMed Mitchell P, Cumming RG, Attebo K, Panchapakesan J (1997) Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 104(4):581–588CrossRefPubMed
5.
go back to reference Keeffe JE, Taylor HR (1996) Cataract surgery in Australia 1985–94. Aust N Zeal J Ophthalmol 24(4):313–317CrossRef Keeffe JE, Taylor HR (1996) Cataract surgery in Australia 1985–94. Aust N Zeal J Ophthalmol 24(4):313–317CrossRef
6.
go back to reference Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JSJN (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in the United States in 2006-2010. Neuro-oncol 15(Suppl_2):ii1–ii56PubMedPubMedCentral Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JSJN (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in the United States in 2006-2010. Neuro-oncol 15(Suppl_2):ii1–ii56PubMedPubMedCentral
8.
go back to reference Barrow DL, Tindall GTJN (1990) Loss of vision after transsphenoidal surgery. Neurosurgery 27(1):60–68CrossRefPubMed Barrow DL, Tindall GTJN (1990) Loss of vision after transsphenoidal surgery. Neurosurgery 27(1):60–68CrossRefPubMed
10.
go back to reference Wilson PJ, Omay SB, Kacker A, Anand VK, Schwartz THJJ (2018) Endonasal endoscopic pituitary surgery in the elderly. J Neurosurg 128(2):429–436CrossRefPubMed Wilson PJ, Omay SB, Kacker A, Anand VK, Schwartz THJJ (2018) Endonasal endoscopic pituitary surgery in the elderly. J Neurosurg 128(2):429–436CrossRefPubMed
15.
go back to reference Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27(8):1304–1305CrossRefPubMed Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27(8):1304–1305CrossRefPubMed
16.
go back to reference Congdon N, Vingerling JR, Klein BEK, West S, Friedman DS, Kempen J, O’Colmain B, Wu Y, Taylor HR, Wang JJ, Grp EDPR (2004) Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol 122(4):487–494CrossRefPubMed Congdon N, Vingerling JR, Klein BEK, West S, Friedman DS, Kempen J, O’Colmain B, Wu Y, Taylor HR, Wang JJ, Grp EDPR (2004) Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol 122(4):487–494CrossRefPubMed
18.
go back to reference Hajiabadi M, Alimohamadi M, Fahlbusch RJW (2015) Decision making for patients with concomitant pituitary macroadenoma and ophthalmologic comorbidity: a clinical controversy. World Neurosurg 84(1):147–153CrossRefPubMed Hajiabadi M, Alimohamadi M, Fahlbusch RJW (2015) Decision making for patients with concomitant pituitary macroadenoma and ophthalmologic comorbidity: a clinical controversy. World Neurosurg 84(1):147–153CrossRefPubMed
19.
go back to reference Phu J, Khuu SK, Yapp M, Assaad N, Hennessy MP, Kalloniatis MJC (2017) Optometry E: the value of visual field testing in the era of advanced imaging: clinical and psychophysical perspectives. 100(4):313–332 Phu J, Khuu SK, Yapp M, Assaad N, Hennessy MP, Kalloniatis MJC (2017) Optometry E: the value of visual field testing in the era of advanced imaging: clinical and psychophysical perspectives. 100(4):313–332
Metadata
Title
Increased frequency of cataract surgery in patients over age 50 with pituitary macroadenomas and chiasmal compression
Authors
Mina M. Gerges
Mohamed M. Arnaout
Abad Cherif El Asri
Matthew D. Cummock
Ahmed Roshdy
Vijay K. Anand
Marc J. Dinkin
Cristiano Oliveira
Theodore H. Schwartz
Publication date
01-08-2019
Publisher
Springer US
Published in
Pituitary / Issue 4/2019
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-019-00970-y

Other articles of this Issue 4/2019

Pituitary 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.